{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:47:40Z","timestamp":1792172860926,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11307-025-02005-4","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:32:15Z","timestamp":1746192735000},"page":"324-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Imaging Value of 18F-FAPI PET\/CT in Sorafenib-Induced Cardiac Dysfunction in Patients with Hepatocellular Carcinoma: Compared with 18F-FDG PET\/CT"],"prefix":"10.1007","volume":"27","author":[{"given":"Yingqi","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"12","key":"2005_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM (2023) Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol 20(12):864\u2013884. https:\/\/doi.org\/10.1038\/s41571-023-00825-3","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"2005_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ et al (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16(10):589\u2013604. https:\/\/doi.org\/10.1038\/s41575-019-0186-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"2005_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1001\/jamaoncol.2023.2677","volume":"10","author":"S Cappuyns","year":"2024","unstructured":"Cappuyns S, Corbett V, Yarchoan M et al (2024) Critical appraisal of guideline recommendations on systemic therapies for advanced hepatocellular carcinoma: a review. JAMA Oncol 10(3):395\u2013404. https:\/\/doi.org\/10.1001\/jamaoncol.2023.2677","journal-title":"JAMA Oncol"},{"issue":"4","key":"2005_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s43018-022-00357-2","volume":"3","author":"JM Llovet","year":"2022","unstructured":"Llovet JM, Pinyol R, Kelley RK et al (2022) Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. Nat Cancer 3(4):386\u2013401. https:\/\/doi.org\/10.1038\/s43018-022-00357-2","journal-title":"Nat Cancer"},{"issue":"16","key":"2005_CR5","doi-asserted-by":"publisher","first-page":"11747","DOI":"10.1021\/acs.jmedchem.0c02167","volume":"64","author":"D Saha","year":"2021","unstructured":"Saha D, Ryan KR, Lakkaniga NR et al (2021) Targeting rearranged during transfection in cancer: a perspective on small-molecule inhibitors and their clinical development. J Med Chem 64(16):11747\u201311773. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c02167","journal-title":"J Med Chem"},{"key":"2005_CR6","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2147\/DDDT.S443107","volume":"18","author":"J Li","year":"2024","unstructured":"Li J, Zhang L, Ge T et al (2024) Understanding sorafenib-induced cardiovascular toxicity: mechanisms and treatment implications. Drug Des Devel Ther 18:829\u2013843. https:\/\/doi.org\/10.2147\/DDDT.S443107","journal-title":"Drug Des Devel Ther"},{"issue":"8","key":"2005_CR7","doi-asserted-by":"publisher","first-page":"e0271631","DOI":"10.1371\/journal.pone.0271631","volume":"17","author":"D Zaafar","year":"2022","unstructured":"Zaafar D, Khalil HMA, Rasheed RA et al (2022) Hesperetin mitigates sorafenib-induced cardiotoxicity in mice through inhibition of the TLR4\/NLRP3 signaling pathway. PLoS ONE 17(8):e0271631. https:\/\/doi.org\/10.1371\/journal.pone.0271631","journal-title":"PLoS ONE"},{"issue":"1","key":"2005_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12964-020-00555-4","volume":"18","author":"F Yousefi","year":"2020","unstructured":"Yousefi F, Shabaninejad Z, Vakili S et al (2020) TGF-\u03b2 and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus. Cell Commun Signal 18(1):87. https:\/\/doi.org\/10.1186\/s12964-020-00555-4","journal-title":"Cell Commun Signal"},{"issue":"11","key":"2005_CR9","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1002\/tox.24362","volume":"39","author":"CH Liu","year":"2024","unstructured":"Liu CH, Ho YC, Lee WC et al (2024) Sodium-glucose co-transporter-2 inhibitor empagliflozin attenuates sorafenib-induced myocardial inflammation and toxicity. Environ Toxicol 39(11):4844\u20134858. https:\/\/doi.org\/10.1002\/tox.24362","journal-title":"Environ Toxicol"},{"issue":"3","key":"2005_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s12265-020-10030-7","volume":"13","author":"RA Feroze","year":"2020","unstructured":"Feroze RA, Leya J, Herron T et al (2020) Clinical and research tools for the study of cardiovascular effects of cancer therapy. J Cardiovasc Transl Res 13(3):417\u2013430. https:\/\/doi.org\/10.1007\/s12265-020-10030-7","journal-title":"J Cardiovasc Transl Res"},{"issue":"5","key":"2005_CR11","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1007\/s12350-023-03202-w","volume":"30","author":"C Valzania","year":"2023","unstructured":"Valzania C, Paccagnella A, Spadotto A et al (2023) Early detection of cancer therapy cardiotoxicity by radionuclide angiography: an update. J Nucl Cardiol 30(5):2104\u20132111. https:\/\/doi.org\/10.1007\/s12350-023-03202-w","journal-title":"J Nucl Cardiol"},{"issue":"11","key":"2005_CR12","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.7150\/thno.19551","volume":"7","author":"J Sourdon","year":"2017","unstructured":"Sourdon J, Lager F, Viel T et al (2017) Cardiac metabolic deregulation induced by the Tyrosine Kinase receptor inhibitor sunitinib is rescued by Endothelin Receptor antagonism. Theranostics 7(11):2757\u20132774. https:\/\/doi.org\/10.7150\/thno.19551","journal-title":"Theranostics"},{"issue":"6","key":"2005_CR13","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s12350-019-01617-y","volume":"27","author":"J Kim","year":"2020","unstructured":"Kim J, Cho SG, Kang SR et al (2020) Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity. J Nucl Cardiol 27(6):2154\u20132163. https:\/\/doi.org\/10.1007\/s12350-019-01617-y","journal-title":"J Nucl Cardiol"},{"key":"2005_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.614997","volume":"8","author":"D Finke","year":"2021","unstructured":"Finke D, Heckmann MB, Herpel E et al (2021) Early detection of checkpoint inhibitor-associated myocarditis using (68)Ga-FAPI PET\/CT. Front Cardiovasc Med 8:614997. https:\/\/doi.org\/10.3389\/fcvm.2021.614997","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"2005_CR15","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.3390\/ijms23073802","volume":"23","author":"D Kersting","year":"2022","unstructured":"Kersting D, Settelmeier S, Mavroeidi IA et al (2022) Shining damaged hearts: immunotherapy-related cardiotoxicity in the spotlight of nuclear cardiology. Int J Mol Sci 23(7):3802. https:\/\/doi.org\/10.3390\/ijms23073802","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2005_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s11604-021-01097-6","volume":"39","author":"R Minamimoto","year":"2021","unstructured":"Minamimoto R (2021) Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET\/CT. Jpn J Radiol 39(6):540\u2013557. https:\/\/doi.org\/10.1007\/s11604-021-01097-6","journal-title":"Jpn J Radiol"},{"issue":"3","key":"2005_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/1874471016666230228102231","volume":"16","author":"Z Shaghaghi","year":"2023","unstructured":"Shaghaghi Z, Jalali Zefrei F, Salari A et al (2023) Promising radiopharmaceutical tracers for detection of cardiotoxicity in cardio-oncology. Curr Radiopharm 16(3):171\u2013184. https:\/\/doi.org\/10.2174\/1874471016666230228102231","journal-title":"Curr Radiopharm"},{"key":"2005_CR18","doi-asserted-by":"publisher","first-page":"25092","DOI":"10.1038\/srep25092","volume":"6","author":"C Marini","year":"2016","unstructured":"Marini C, Ravera S, Buschiazzo A et al (2016) Discovery of a novel glucose metabolism in cancer: the role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt. Sci Rep 6:25092. https:\/\/doi.org\/10.1038\/srep25092","journal-title":"Sci Rep"},{"issue":"3","key":"2005_CR19","doi-asserted-by":"publisher","first-page":"e004796","DOI":"10.1161\/JAHA.113.004796","volume":"2","author":"S Sen","year":"2013","unstructured":"Sen S, Kundu BK, Wu HC et al (2013) Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart. J Am Heart Assoc 2(3):e004796. https:\/\/doi.org\/10.1161\/JAHA.113.004796","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2005_CR20","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"Y Octavia","year":"2012","unstructured":"Octavia Y, Tocchetti CG, Gabrielson KL et al (2012) Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 52(6):1213\u20131225. https:\/\/doi.org\/10.1016\/j.yjmcc.2012.03.006","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"2005_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40959-023-00161-6","volume":"9","author":"MMC Becker","year":"2023","unstructured":"Becker MMC, Arruda GFA, Berenguer DRF et al (2023) Anthracycline cardiotoxicity: current methods of diagnosis and possible role of (18)F-FDG PET\/CT as a new biomarker. Cardiooncology 9(1):17. https:\/\/doi.org\/10.1186\/s40959-023-00161-6","journal-title":"Cardiooncology"},{"issue":"18","key":"2005_CR22","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.3390\/jcm12186033","volume":"12","author":"Y Cui","year":"2023","unstructured":"Cui Y, Wang Y, Wang S et al (2023) Highlighting fibroblasts activation in fibrosis: the state-of-the-art fibroblast activation protein inhibitor PET imaging in cardiovascular diseases. J Clin Med 12(18):6033. https:\/\/doi.org\/10.3390\/jcm12186033","journal-title":"J Clin Med"},{"issue":"3","key":"2005_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11886-022-01641-4","volume":"24","author":"JM Kelly","year":"2022","unstructured":"Kelly JM, Babich JW (2022) PET tracers for imaging cardiac function in cardio-oncology. Curr Cardiol Rep 24(3):247\u2013260. https:\/\/doi.org\/10.1007\/s11886-022-01641-4","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"2005_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/annonc\/mdy510","volume":"30","author":"A Vogel","year":"2019","unstructured":"Vogel A, Cervantes A, Chau I et al (2019) Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30(5):871\u2013873. https:\/\/doi.org\/10.1093\/annonc\/mdy510","journal-title":"Ann Oncol"},{"issue":"6","key":"2005_CR25","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s00259-012-2096-x","volume":"39","author":"V Goh","year":"2012","unstructured":"Goh V, Sarker D, Osmani S et al (2012) Functional imaging techniques in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 39(6):1070\u20131079. https:\/\/doi.org\/10.1007\/s00259-012-2096-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2005_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40644-023-00626-y","volume":"23","author":"J Zhang","year":"2023","unstructured":"Zhang J, Jiang S, Li M et al (2023) Head-to-head comparison of (18)F-FAPI and (18)F-FDG PET\/CT in staging and therapeutic management of hepatocellular carcinoma. Cancer Imaging 23(1):106. https:\/\/doi.org\/10.1186\/s40644-023-00626-y","journal-title":"Cancer Imaging"},{"issue":"41","key":"2005_CR27","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS et al (2022) 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO), and the International Cardio-Oncology Society (IC-OS). Eur Heart J 43(41):4229\u20134361. https:\/\/doi.org\/10.1093\/eurheartj\/ehac244","journal-title":"Eur Heart J"},{"issue":"36","key":"2005_CR28","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"1","key":"2005_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12967-018-1670-9","volume":"16","author":"M Sarocchi","year":"2018","unstructured":"Sarocchi M, Bauckneht M, Arboscello E et al (2018) An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline. J Transl Med 16(1):295. https:\/\/doi.org\/10.1186\/s12967-018-1670-9","journal-title":"J Transl Med"},{"issue":"2","key":"2005_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5603\/NMR.2021.0019","volume":"24","author":"N Jokar","year":"2021","unstructured":"Jokar N, Amini A, Ravanbod M et al (2021) State-of-the-art modalities in cardio-oncology: insight from a nuclear medicine approach. Nucl Med Rev Cent East Eur 24(2):82\u201392. https:\/\/doi.org\/10.5603\/NMR.2021.0019","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"2005_CR31","doi-asserted-by":"publisher","first-page":"107017","DOI":"10.1016\/j.phrs.2023.107017","volume":"198","author":"S Liu","year":"2023","unstructured":"Liu S, Yue S, Guo Y et al (2023) Sorafenib induces cardiotoxicity through RBM20-mediated alternative splicing of sarcomeric and mitochondrial genes. Pharmacol Res 198:107017. https:\/\/doi.org\/10.1016\/j.phrs.2023.107017","journal-title":"Pharmacol Res"},{"issue":"2","key":"2005_CR32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/bcpt.13318","volume":"126","author":"W Ma","year":"2020","unstructured":"Ma W, Liu M, Liang F et al (2020) Cardiotoxicity of sorafenib is mediated through elevation of ROS level and CaMKII activity and dysregulation of calcium homoeostasis. Basic Clin Pharmacol Toxicol 126(2):166\u2013180. https:\/\/doi.org\/10.1111\/bcpt.13318","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"7","key":"2005_CR33","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3390\/jcm9072279","volume":"9","author":"A Haider","year":"2020","unstructured":"Haider A, Bengs S, Schade K et al (2020) Myocardial (18)F-FDG uptake pattern for cardiovascular risk stratification in patients undergoing oncologic PET\/CT. J Clin Med 9(7):2279. https:\/\/doi.org\/10.3390\/jcm9072279","journal-title":"J Clin Med"},{"issue":"6","key":"2005_CR34","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.36660\/abc.20210463","volume":"118","author":"MLC Dourado","year":"2022","unstructured":"Dourado MLC, Dompieri LT, Leit\u00e3o GM et al (2022) Chemotherapy-induced cardiac18F-FDG uptake in patients with lymphoma: an early metabolic index of cardiotoxicity? Arq Bras Cardiol 118(6):1049\u20131058. https:\/\/doi.org\/10.36660\/abc.20210463","journal-title":"Arq Bras Cardiol"},{"issue":"8","key":"2005_CR35","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1007\/s00259-024-06673-2","volume":"51","author":"Z Wei","year":"2024","unstructured":"Wei Z, Xu H, Chen B et al (2024) Early detection of anthracycline-induced cardiotoxicity using [(68)Ga]Ga-FAPI-04 imaging. Eur J Nucl Med Mol Imaging 51(8):2204\u20132215. https:\/\/doi.org\/10.1007\/s00259-024-06673-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2005_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W Tang","year":"2020","unstructured":"Tang W, Chen Z, Zhang W et al (2020) The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther 5(1):87. https:\/\/doi.org\/10.1038\/s41392-020-0187-x","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2005_CR37","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1053\/j.gastro.2021.12.276","volume":"162","author":"GL Su","year":"2022","unstructured":"Su GL, Altayar O, O\u2019Shea R et al (2022) AGA clinical practice guideline on systemic therapy for hepatocellular carcinoma. Gastroenterology 162(3):920\u2013934. https:\/\/doi.org\/10.1053\/j.gastro.2021.12.276","journal-title":"Gastroenterology"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-025-02005-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T15:34:28Z","timestamp":1749742468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-025-02005-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2005"],"URL":"https:\/\/doi.org\/10.1007\/s11307-025-02005-4","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}